Detalles de la búsqueda
1.
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38764356
2.
Nationwide questionnaire survey on the management of chronic kidney disease for general practitioners in Japan.
Clin Exp Nephrol
; 25(10): 1093-1102, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34251522
3.
Survey of the current status of subclinical coronavirus disease 2019 (COVID-19).
J Infect Chemother
; 26(12): 1294-1300, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32958395
4.
Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring.
Clin Exp Hypertens
; 41(7): 637-644, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30373408
5.
A questionnaire survey of general practitioners in Japan's Kanagawa Prefecture for the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014.
Clin Exp Hypertens
; 39(8): 705-710, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28886258
6.
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Hypertens Res
; 47(3): 628-638, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37848562
7.
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study.
Front Pharmacol
; 15: 1358573, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601470
8.
Cross-sectional survey of hypertension management in clinical practice in Japan: the Kanagawa Hypertension Study 2021 conducted in collaboration with Japan Medical Association Database of Clinical Medicine.
Hypertens Res
; 46(11): 2447-2459, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532949
9.
Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
J Cardiol
; 81(4): 385-389, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109256
10.
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication.
Diab Vasc Dis Res
; 20(6): 14791641231222837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096503
11.
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Cardiovasc Endocrinol Metab
; 12(4): e0292, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37779602
12.
Concomitant treatment with insulin and sodium-glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score-matched analysis.
J Diabetes Investig
; 13(9): 1520-1527, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524473
13.
Impact of the first announced state of emergency owing to coronavirus disease 2019 on stress and blood pressure levels among patients with type 2 diabetes mellitus in Japan.
J Diabetes Investig
; 13(9): 1607-1616, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35437922
14.
Polypharmacy influences the renal composite outcome in patients treated with sodium-glucose cotransporter 2 inhibitors.
Clin Transl Sci
; 15(4): 1050-1062, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34989473
15.
Influence of stress induced by the first announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan.
Hypertens Res
; 45(4): 675-685, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952950
16.
Comparison of the 2013 and 2019 Nationwide Surveys on the Management of Chronic Kidney Disease by General Practitioners in Japan.
J Clin Med
; 11(16)2022 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36013020
17.
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Sci Rep
; 12(1): 16106, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167964
18.
Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Intern Med
; 61(2): 159-165, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34744105
19.
The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021.
Intern Med
; 61(20): 3053-3062, 2022 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945024
20.
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Diabetes Res Clin Pract
; 185: 109231, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131376